Pharmalucence Kit for the Preparation of Technetium Tc 99m Sestamibi Injection for Mycardial and Breast Imaging. For Intravenous Use and Reconstitution. a) Five vials kits: NDC# 45567-0555-1, b) Thirty vials kits: NDC# 45567-0555-2, Rx Only, Manufactured by: Pharmalucence, Inc., Billerica, MA 01821
Published July 31, 2013 · Recall initiated: May 30, 2013
Summary
FDA records drug Class III recall D-808-2013, published July 31, 2013 and initiated May 30, 2013. Recalling firm: Pharmalucence, Inc.; Status: Terminated; Reported quantity: 17,260 vials; Lot: Lot 280011, Exp 08/13. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter; particulate found in retain samples
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Pharmalucence, Inc.
- Distributor
- Nationwide & Bahamas, Barbados, Bermuda, Japan
- Lot
- Lot 280011, Exp 08/13
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAKit for the Preparation of Technetium Tc99m Medronate, 20mg in 10 mL vial, packaged in a) 5-count box (NDCAugust 15, 2018
- FDAKit for the Preparation of Technetium TC-99M Mebrofenin, 45 mg in 10 mL (5 count), NDC 45567-0455-1 and (30May 23, 2018
- FDAMitosol (mitomycin for solution), 0.2 mg/vial, Kit for Ophthalmic Use (NDC 49771-002-01), 3 kits per box (NDCJuly 31, 2013
- FDAMagnesium Sulfate 2 grams in Dextrose 5% for Injection, in 50 mL Plastic Infusion Bags, Med Prep ConsultingJuly 31, 2013
- FDAHydra Vision DR 60/80 System, Models 700539 and 700540, Liebel-Flarshiem Company. The System is used inJuly 24, 2013
- FDAExactaMix 1200 and 2400 Compounders. Used as an automated pumping system that compounds multiple sterileJuly 24, 2013
Questions about this recall
Was Pharmalucence Kit for the Preparation of Technetium Tc 99m Sestamibi Injection for Mycardial and Breast Imaging. For Intravenous Use and Reconstitution. a) Five vials kits: NDC# 45567-0555-1, b) Thirty vials kits: NDC# 45567-0555-2, Rx Only, Manufactured by: Pharmalucence, Inc., Billerica, MA 01821 recalled?
Yes. FDA published recall D-808-2013 on July 31, 2013. Reported hazard: Presence of Particulate Matter; particulate found in retain samples
What should I do if I have this product?
Voluntary: Firm initiated · Letter